Intravitreal triamcinolone acetonide treatment of tamoxifen maculopathy with associated cystoid macular edema

Retin Cases Brief Rep. 2015 Winter;9(1):64-6. doi: 10.1097/ICB.0000000000000093.

Abstract

Purpose: To report a case of severe tamoxifen-induced maculopathy with associated cystoid macular edema treated with intravitreal triamcinolone acetonide.

Methods: Case report.

Results: The patient presented with bilateral cystoid macular edema that persisted despite treatment, which included intravitreal bevacizumab injections. He received 7 triamcinolone injections in each eye over 20 months, resulting in the most recent best-corrected Snellen visual acuities of 20/40 in the right eye and 20/30 in the left eye. Complete resolution of the cystoid macular edema was achieved in each eye, but recurrent edema necessitated continued intermittent injections. Macular crystals persisted despite treatment but decreased since presentation.

Conclusion: Intravitreal triamcinolone should be considered for treatment of tamoxifen-associated macular edema, especially if the condition responds poorly to anti-vascular endothelial growth factor treatments.

Publication types

  • Case Reports

MeSH terms

  • Anti-Inflammatory Agents / administration & dosage*
  • Antineoplastic Agents, Hormonal / adverse effects*
  • Humans
  • Intravitreal Injections
  • Macular Edema / chemically induced
  • Macular Edema / drug therapy*
  • Male
  • Middle Aged
  • Tamoxifen / adverse effects*
  • Treatment Outcome
  • Triamcinolone Acetonide / administration & dosage*

Substances

  • Anti-Inflammatory Agents
  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Triamcinolone Acetonide